2019: the year of the pharma mega-merger

2019 will be remembered as the year of the pharma mega-merger. Richard Staines looks back at a year that changed the landscape of big pharma

Xtandi catches up with Erleada in castration-sensitive prost...

Pfizer and the UK cancer landscape: the pharmaphorum podcast

Pfizer’s Dr Olivia Ashman joined me for episode 16 of the pharmaphorum podcast, which focuses on the UK cancer landscape.

NICE backs Ibrance for breast cancer via Cancer Drugs Fund

Takeda sets sights on first-line lung cancer market with new...

13th Annual Pharma Resource Planning and Portfolio Managemen...

Prioritizing Projects with Tools, Data, and Governance